L B T A
- Product NDC
- 82932-602
- Requested package NDC
- 82932-602-01
- 11-digit product format
- 829320602
- Labeler code
- 82932
- Product ID
- 82932-602_ebc3aa38-349a-e43e-e053-2995a90a6d5b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- CALCIUM CARBONATE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- QN SCIENCE Co Ltd
- Application
- part331
- Marketing category
- OTC MONOGRAPH FINAL
- Marketing start
- 2022-09-09
- Marketing end
- 0000-00-00
- Substance
- CALCIUM CARBONATE
- Active strength
- 56 mg/1001
- Pharmacologic classes
- Blood Coagulation Factor [EPC], Calcium [CS], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 82932-602-01 | 82932060201 | 100 TABLET in 1 BLISTER PACK (82932-602-01) | 100 tablet | 2022-09-09 | 0000-00-00 | No | No | Current |